REPURGENESIS CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Integrated AI Drug Discovery Platform: An AI-driven multi-model platform that accelerates drug repurposing by integrating diverse data types, multiple R&D methodologies, various analytical modalities, and a wide range of AI algorithms.
The content above was translated by Ai
Founded Year
2025
Unified Business No.
60593116
Status
Active
Number of Employees
0
Total Paid-in
Capital
95,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
REPURGENESIS is an AI-driven biotechnology company that has pioneered the “Intelligent Orchestrating” paradigm. By coordinating multiple models, diverse datasets, and multimodal mechanisms, it comprehensively accelerates the end-to-end drug repurposing process. Through an AI-orchestrated ecosystem, REPURGENESIS integrates molecular structure modeling, omics analysis, knowledge graph reasoning, and clinical evidence mining to uncover new therapeutic potential in existing drugs—seamlessly bridging computational discovery and experimental validation within a continuous and intelligent cycle.
The content above was translated by Ai
